FDA Approved Products
| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|
| 213498 | NDA | VANDA PHARMS INC | | 001 | PONVORY | TABLET;ORAL | 2MG | PONESIMOD | 2021-03-18 | Prescription | Yes |
| 002 | PONVORY | TABLET;ORAL | 3MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 003 | PONVORY | TABLET;ORAL | 4MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 004 | PONVORY | TABLET;ORAL | 5MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 005 | PONVORY | TABLET;ORAL | 6MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 006 | PONVORY | TABLET;ORAL | 7MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 007 | PONVORY | TABLET;ORAL | 8MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 008 | PONVORY | TABLET;ORAL | 9MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 009 | PONVORY | TABLET;ORAL | 10MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 010 | PONVORY | TABLET;ORAL | 20MG | PONESIMOD | 2021-03-18 | Prescription | No |
| 214517 | NDA | VANDA PHARMS INC | | 001 | HETLIOZ LQ | SUSPENSION;ORAL | 4MG/ML | TASIMELTEON | 2020-12-01 | Prescription | Yes |
| 002 | HETLIOZ LQ | SUSPENSION;ORAL | 4MG/ML | TASIMELTEON | 2020-12-01 | Prescription | No |
| 205677 | NDA | VANDA PHARMS INC | | 001 | HETLIOZ | CAPSULE;ORAL | 20MG | TASIMELTEON | 2014-01-31 | Prescription | Yes |
| 022192 | NDA | VANDA PHARMS INC | | 001 | FANAPT | TABLET;ORAL | 1MG | ILOPERIDONE | 2009-05-06 | Prescription | Yes |
| 002 | FANAPT | TABLET;ORAL | 2MG | ILOPERIDONE | 2009-05-06 | Prescription | No |
| 003 | FANAPT | TABLET;ORAL | 4MG | ILOPERIDONE | 2009-05-06 | Prescription | No |
| 004 | FANAPT | TABLET;ORAL | 6MG | ILOPERIDONE | 2009-05-06 | Prescription | No |
| 005 | FANAPT | TABLET;ORAL | 8MG | ILOPERIDONE | 2009-05-06 | Prescription | No |
| 006 | FANAPT | TABLET;ORAL | 10MG | ILOPERIDONE | 2009-05-06 | Prescription | No |
| 007 | FANAPT | TABLET;ORAL | 12MG | ILOPERIDONE | 2009-05-06 | Prescription | No |